Subarachnoid hemorrhage (SAH) is a neurological emergency with mortality rates that can exceed 40%. Prompt and accurate grading is critical for guiding clinical decisions. The Fisher Scale remains one of the most widely used radiographic grading tools in SAH management. It helps clinicians predict the risk of cerebral vasospasm, one of the most feared complications following aneurysmal SAH.
Understanding how grading scales work is essential for neuroscience and stroke nurses. Knowing how to apply them in acute care settings supports faster decision-making and clearer interdisciplinary communication.
Understanding Subarachnoid Hemorrhage and Why Grading Matters
SAH occurs when blood enters the subarachnoid space, most often due to a ruptured cerebral aneurysm. The volume and distribution of blood visible on imaging are strong predictors of secondary injury. Vasospasm, delayed cerebral ischemia, and hydrocephalus are all associated with the extent of hemorrhage. Grading systems give clinicians a standardized way to assess severity and communicate risk across care teams.

A consistent grading language supports earlier intervention and more coordinated care. This is especially critical in high-volume stroke and neuroscience centers where rapid triage is the norm. Standardized grading also enables more meaningful outcome comparisons across institutions and research studies.
The Fisher Scale: Radiographic Classification of SAH
Introduced in 1980, the original Fisher Scale classifies SAH based on blood appearance on non-contrast CT imaging. It assigns patients to one of four grades:
Grade 1: No blood detected on CT
2: Diffuse or vertical layers of subarachnoid blood less than 1 mm thick
3: Localized clot or vertical layer of blood 1 mm or greater in thickness
4: Intracerebral or intraventricular clot, with or without diffuse subarachnoid blood
Grade 3 carries the highest predicted risk of vasospasm in the original scale. Experts designed the Fisher Scale to predict symptomatic vasospasm, not overall clinical severity. It does not account for the patient's neurological status at presentation. This distinction is important when integrating the scale into clinical workflows alongside other assessment tools.
The Modified Fisher Scale and Complementary Grading Tools
The Modified Fisher Scale, developed by Claassen and colleagues in 2001, addressed limitations of the original. It incorporated the presence of intraventricular hemorrhage and revised the classification of blood distribution. Research has shown that the Modified Fisher Scale improves predictive accuracy for delayed cerebral ischemia.

Other scales serve complementary clinical purposes:
Hunt and Hess Scale: Grades neurological status at presentation from Grade I (mild headache, no neurological deficit) to Grade V (deep coma, decerebrate posturing). It is widely used to assess surgical risk and predict overall outcome.
World Federation of Neurological Surgeons (WFNS) Scale: Combines the Glasgow Coma Scale score with the presence or absence of a motor deficit. It is considered more objective and reproducible than the Hunt and Hess Scale.
Clinical Implications for Neuroscience Nursing Practice
Grading scales are not merely documentation tools. They directly inform nursing priorities and patient monitoring plans. A patient with a Modified Fisher Grade 3 or 4 requires vigilant neurological monitoring for signs of vasospasm. Vasospasm typically peaks between days 4 and 14 after the initial bleed. Early detection of neurological change can be the difference between timely intervention and permanent deficit.
Neuroscience and stroke nurses are often the first to detect subtle changes in a patient's neurological status. A working knowledge of SAH grading helps nurses contextualize those observations. It supports more effective handoff communication, earlier escalation, and stronger collaboration with the neurosurgical team. Grading literacy is a professional competency that extends well beyond the physician's role.
Nurses who can accurately interpret grading findings position themselves better to advocate for their patients. This includes communicating clinical changes in a language that resonates with the entire care team. It also means recognizing when a patient's trajectory does not align with their grade. This discrepancy may signal a complication requiring immediate attention.
Advance Your Expertise in Neuroscience Nursing
Staying current on clinical tools like SAH grading scales is part of delivering high-quality, evidence-based care. The American Association of Neuroscience Nurses (AANN) provides continuing education and stroke-focused resources to help support your practice.
Learn more about the Stroke Certified Registered Nurse (SCRN) credential. The SCRN credential formally recognizes the attainment and demonstration of a unique body of knowledge necessary for the practice of stroke nursing.
Frequently Asked Questions
What is the difference between the Fisher Scale and the Hunt and Hess Scale? The Fisher Scale is a radiographic tool based on CT imaging findings, specifically designed to predict the risk of vasospasm. The Hunt and Hess Scale assesses the patient’s neurological status at presentation and predicts surgical risk and overall outcome. The two scales measure different dimensions of SAH severity and clinicians typically use them together to obtain a more complete picture.
Is the Modified Fisher Scale replacing the original Fisher Scale in clinical practice? The Modified Fisher Scale is increasingly preferred in research and many clinical settings because of its improved predictive accuracy for delayed cerebral ischemia. However, the original Fisher Scale remains in common use. Institutional protocols vary, so familiarity with both versions is valuable in practice.
Can a patient have a high Fisher Scale grade but a mild clinical presentation? Yes. The Fisher Scale reflects radiographic findings only. A patient may have a large clot burden on CT but present with minimal neurological deficits. Conversely, a patient with a low Fisher grade may still have significant clinical impairment. This is precisely why combining the Fisher Scale with a clinical grading tool like the WFNS Scale is important.
What is delayed cerebral ischemia and how does it differ from vasospasm? Vasospasm refers to the narrowing of cerebral arteries following SAH, which can reduce blood flow to the brain. Delayed cerebral ischemia (DCI) is a broader term that describes the clinical deterioration resulting from that reduced perfusion. Not all patients with radiographic vasospasm develop DCI, and some develop DCI without documented vasospasm. The Modified Fisher Scale was developed specifically to improve prediction of DCI risk.
